Clinical Grade Non-Transfusable Leukopaks®, Fresh
Clinical Grade Non-Transfusable Leukopaks® provide an enriched peripheral blood mononuclear cell (PBMC) fraction with low granulocytes and red blood cells. This highly enriched PBMC fraction requires minimal downstream processing (i.e. Ficoll) and can be used directly for isolating high-yields of immune cells, such as CD4+ T cells, CD8+ T cells, CD19+ B cells, monocytes, and a variety of other immune cells and subsets. This allows researchers greater reproducibility of experiments from a single donor (minimizing donor-to-donor variation), scalability of experiments from a single cell type, and a decrease in same cell variability. Up to 12 Leukopaks® collections can be performed on the same donor in a given year, providing an ample amount of MNCs for large-scale experiments and research studies.
• Enriched PBMCs
• 0.1-0.2% CD34+ cells
• Low hematocrit
• Low granulocytes
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols. All reagents and devices used in the collection process are certified clinical grade.
This item is for research use only.
|Cell and Tissue Source||Peripheral Blood|
|Donor Attributes||HIV-, HepB-, HepC-|
|Viability||≥90% by Flow Cytometry|